Corrigendum to “Transferrin-guided intelligent nanovesicles augment the targetability and potency of clinical PLK1 inhibitor to acute myeloid leukemia” [Bioact. Mater. 21 (March 2023) 499–510]
Source abstract
Abstract
[This corrects the article DOI: 10.1016/j.bioactmat.2022.08.032.].
Only a short abstract or summary was supplied by the source.
Source: openalex_inverted_index · Quality: short
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Acute Myeloid Leukemia Research · Graphene and Nanomaterials Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References
Reference metadata was not supplied for this record.